Ding, Dalian
Manohar, Senthilvelan
Kador, Peter F.
Salvi, Richard
Article History
Received: 29 April 2024
Accepted: 1 July 2024
First Online: 3 July 2024
Competing interests
: Dr. Peter Kador, Therapeutic Vision, developed and holds patents on the HK-2 molecule used in this study. All other authors do not have any competing interest.